Notice: This company has been marked as potentially delisted and may not be actively trading. Tocagen (TOCA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends TOCA vs. INVA, OPK, GYRE, MRVI, PAHC, ELVN, COLL, ZYME, COGT, and PHVSShould you be buying Tocagen stock or one of its competitors? The main competitors of Tocagen include Innoviva (INVA), OPKO Health (OPK), Gyre Therapeutics (GYRE), Maravai LifeSciences (MRVI), Phibro Animal Health (PAHC), Enliven Therapeutics (ELVN), Collegium Pharmaceutical (COLL), Zymeworks (ZYME), Cogent Biosciences (COGT), and Pharvaris (PHVS). These companies are all part of the "medical" sector. Tocagen vs. Innoviva OPKO Health Gyre Therapeutics Maravai LifeSciences Phibro Animal Health Enliven Therapeutics Collegium Pharmaceutical Zymeworks Cogent Biosciences Pharvaris Innoviva (NASDAQ:INVA) and Tocagen (NASDAQ:TOCA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, community ranking, media sentiment, profitability, risk, institutional ownership and analyst recommendations. Which has stronger valuation & earnings, INVA or TOCA? Innoviva has higher revenue and earnings than Tocagen. Tocagen is trading at a lower price-to-earnings ratio than Innoviva, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnoviva$310.46M3.65$179.72M$0.6926.20Tocagen$40K6,565.77-$63.52M-$2.69-4.08 Do analysts prefer INVA or TOCA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innoviva 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tocagen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is INVA or TOCA more profitable? Innoviva has a net margin of 18.31% compared to Tocagen's net margin of -176,433.34%. Innoviva's return on equity of 20.84% beat Tocagen's return on equity.Company Net Margins Return on Equity Return on Assets Innoviva18.31% 20.84% 11.38% Tocagen -176,433.34%-327.74%-111.87% Does the media prefer INVA or TOCA? In the previous week, Innoviva had 3 more articles in the media than Tocagen. MarketBeat recorded 3 mentions for Innoviva and 0 mentions for Tocagen. Innoviva's average media sentiment score of 1.18 beat Tocagen's score of 0.00 indicating that Innoviva is being referred to more favorably in the media. Company Overall Sentiment Innoviva Positive Tocagen Neutral Does the MarketBeat Community favor INVA or TOCA? Innoviva received 58 more outperform votes than Tocagen when rated by MarketBeat users. However, 66.03% of users gave Tocagen an outperform vote while only 57.44% of users gave Innoviva an outperform vote. CompanyUnderperformOutperformInnovivaOutperform Votes30157.44% Underperform Votes22342.56% TocagenOutperform Votes24366.03% Underperform Votes12533.97% Do insiders & institutionals have more ownership in INVA or TOCA? 99.1% of Innoviva shares are held by institutional investors. Comparatively, 21.4% of Tocagen shares are held by institutional investors. 1.7% of Innoviva shares are held by insiders. Comparatively, 10.9% of Tocagen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, INVA or TOCA? Innoviva has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Tocagen has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. SummaryInnoviva beats Tocagen on 14 of the 17 factors compared between the two stocks. Get Tocagen News Delivered to You Automatically Sign up to receive the latest news and ratings for TOCA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOCA vs. The Competition Export to ExcelMetricTocagenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$262.63M$7.06B$5.84B$9.14BDividend YieldN/A2.76%4.76%3.85%P/E Ratio-4.632.9318.2614.95Price / Sales6,565.77281.18434.4770.76Price / CashN/A65.9238.4235.17Price / Book24.406.717.644.65Net Income-$63.52M$138.11M$3.18B$245.69M Tocagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOCATocagenN/A$10.98+2.6%N/A+1,458.9%$262.63M$40,000.00-4.6377INVAInnoviva3.1138 of 5 stars$18.20-1.2%N/A+15.4%$1.14B$310.46M26.38100Analyst DowngradeNews CoverageOPKOPKO Health4.0141 of 5 stars$1.65+2.5%$2.75+66.7%+66.3%$1.13B$711.41M-8.683,930GYREGyre Therapeutics0.2947 of 5 stars$11.91-1.6%N/A-18.3%$1.11B$105.03M0.0040MRVIMaravai LifeSciences4.0154 of 5 stars$4.30-6.1%$10.28+139.1%-21.9%$1.09B$288.95M-2.62610Options VolumeNews CoverageGap UpPAHCPhibro Animal Health3.8745 of 5 stars$26.22+10.7%$21.00-19.9%+79.6%$1.06B$1.11B54.631,940Analyst RevisionHigh Trading VolumeELVNEnliven Therapeutics1.8273 of 5 stars$21.55-2.0%$38.25+77.5%+34.9%$1.05BN/A-11.3450COLLCollegium Pharmaceutical3.901 of 5 stars$30.52-1.0%$43.60+42.9%-8.3%$984.27M$566.77M13.16210News CoverageZYMEZymeworks2.1069 of 5 stars$14.19-0.6%$19.17+35.1%+22.6%$977.41M$76.01M-9.46460COGTCogent Biosciences1.5478 of 5 stars$8.76+0.2%$14.33+63.6%-6.5%$967.65MN/A-3.5380PHVSPharvaris2.2253 of 5 stars$17.85-2.4%$40.50+126.9%-40.7%$933.38MN/A-6.3830Positive News Related Companies and Tools Related Companies Innoviva Alternatives OPKO Health Alternatives Gyre Therapeutics Alternatives Maravai LifeSciences Alternatives Phibro Animal Health Alternatives Enliven Therapeutics Alternatives Collegium Pharmaceutical Alternatives Zymeworks Alternatives Cogent Biosciences Alternatives Pharvaris Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TOCA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tocagen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tocagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
